Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/13/2003WO2003066034A3 Use of compounds and compositions derived form olives for protecting cells against dna damage
11/13/2003WO2003064997A3 Microarrays produced by cross-sectioning multi-sample plates
11/13/2003WO2003064687A3 Prognostic and treatment methods relating to fibrotic liver disease
11/13/2003WO2003060470A3 Breast cancer expression profiling
11/13/2003WO2003057165A3 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
11/13/2003WO2003047738A3 Liquid interface configurations for automated patch clamp recording
11/13/2003WO2003045314A3 Mhyps as modifiers of branching morphogenesis and methods of use
11/13/2003WO2003045310A3 Digital assay
11/13/2003WO2003040691A3 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
11/13/2003WO2003040689A3 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003039702A3 Methods and compositions for chromatography
11/13/2003WO2003035671A3 Methods for detecting genetic haplotypes by interaction with probes
11/13/2003WO2003034034A9 Automated system and method for processing multiple liquid-based specimens
11/13/2003WO2003032948A3 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003031935A3 System, method, and apparatus for disease susceptibility testing
11/13/2003WO2003031928A3 Cellular engineering, protein expression profiling, differential labeling of peptides, and novel reagents therefor
11/13/2003WO2003029827A3 A method of detecting intracellular protein-protein interactions using three heterologous conjugates
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003025567A3 Production of support-bonded molecules by means of oligonucleotide tags
11/13/2003WO2003021231A9 Method and apparatus for normalization and deconvolution of assay data
11/13/2003WO2003018830A3 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
11/13/2003WO2003015703A3 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
11/13/2003WO2003014738A3 Substance support provided with a marking
11/13/2003WO2003014701A3 Potentiometric probe compounds
11/13/2003WO2003011019A3 Lethal mouse model for testing of pharmaceuticals and vaccines against neospororis
11/13/2003WO2003006923A3 Method and device for determination of and imaging of an environment subjectively taken to be real by a person
11/13/2003WO2003004605A3 Mesenchymal cells and osteoblasts from human embryonic stem cell
11/13/2003WO2003002755A3 Glaucoma treatments with reduced hyperpigmentation
11/13/2003WO2003000889A3 Identification of ses-1 and the uses of the same
11/13/2003WO2003000117A3 Detection and treatment of prostate cancer
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002098358A3 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002092831A3 Method for identifying ligands for g protein coupled receptors
11/13/2003WO2002090995A3 Assay system
11/13/2003WO2002086448A3 Detection of microsatellite instability and its use in diagnosis of tumors
11/13/2003WO2002081630A3 Use of semenogelin in the diagnosis, prognosis and treatment of cancer
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
11/13/2003WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases
11/13/2003WO2002076203A3 Method and system for preparing tissue samples for histological and pathological examination
11/13/2003WO2002075609A3 Predicting metabolic stability of drug molecules
11/13/2003WO2002069198A3 Hla ligand database utilizing predictive algorithms and methods of making and using same
11/13/2003WO2002067956A3 Method for purifying a biological composition
11/13/2003WO2002066972A3 Methods and means for determining fitness in plants
11/13/2003WO2002066681A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
11/13/2003WO2002065126A8 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
11/13/2003WO2002057779A8 Cloning and expression of a new mcp receptor in glial cells
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002056893A8 Novel receptors for $i(helicobacter pylori) and use thereof
11/13/2003WO2002050538A8 Sea-trosy and related methods
11/13/2003WO2002048715A3 Inflammatory markers for detection and prevention of diabetes mellitus
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2001090419A9 Methods for genetic analysis of dna to detect sequence variances
11/13/2003US20030212502 System for a non-invasive online discrete measurement of phase levels in converters or pyromet allurgical furnaces
11/13/2003US20030212497 Relative rates of cytochrome p450 metabolism
11/13/2003US20030212496 Indirect measurement of nitrogen in a multi-component gas by measuring the speed of sound at two states of the gas
11/13/2003US20030212455 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme
11/13/2003US20030212424 Method and apparatus for lancet actuation
11/13/2003US20030212423 Analyte test element with molded lancing blade
11/13/2003US20030212347 Devices and methods for accessing and analyzing physiological fluid
11/13/2003US20030212345 Minimal procedure analyte test system
11/13/2003US20030212317 Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
11/13/2003US20030212265 Detection using genetic engineered nucleic acid
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212253 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema
11/13/2003US20030212179 Slurry containing multimetallic filler
11/13/2003US20030212147 Screening drug for activity for overexpression of enzyme
11/13/2003US20030212132 Determination binding of gabapentin to cells
11/13/2003US20030212037 Use of bvdu for inhibiting the growth of hyperproliferative cells
11/13/2003US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration
11/13/2003US20030212016 Methods and compositions for the treatment and diagnosis of body weight disorders
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211968 Neuromedin u receptor nmur2 and nucleotides encoding it
11/13/2003US20030211967 Method for selectively inhibiting ghrelin action
11/13/2003US20030211964 Method of inhibiting pathogenicity of infectious agents
11/13/2003US20030211637 Single particle electrochemical sensors and methods of utilization
11/13/2003US20030211636 Determining dosage of drugs metabolized by cytochrome P450 such as 2-methoxy-5-trifluoromethoxy-benzyl)-(2-phenyl-piperidin-3-yl)-amine; antibodies
11/13/2003US20030211635 Biological material detecting articles of manufacture
11/13/2003US20030211634 Method for adding an apparent non-signal line to a lateral flow assay
11/13/2003US20030211626 Pulsed-flow total organic carbon analyzer
11/13/2003US20030211625 Method and apparatus for non-invasive monitoring of blood substances using self-sampled tears
11/13/2003US20030211624 Screening mammary gland aspirates for tumor markers; tumor diagnosis
11/13/2003US20030211623 Hydroxyeicosatetraenoic acid (20-HETE); labeling with 2-(2,3-naphthalimino)ethyl trifluoromethanesulfonate in reaction catalyzed by N,N-diisopropylethylamine
11/13/2003US20030211622 Methods and compositions to assess oxidative brain injury
11/13/2003US20030211621 Continuous on-line process control of residua distillation
11/13/2003US20030211619 Packaging material for biosensors; microfluidics; efficient self-monitoring apparatus
11/13/2003US20030211617 Blood glucose meter that reminds the user to test after a hypoglycemic event
11/13/2003US20030211616 System for evaluating and measuring physiological fluids; microfluidics; single-dose packaging of liquid solutions and substances
11/13/2003US20030211615 System for detection of a functional interaction between a compound and a cellular signal transduction component
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211599 Miniature achromosomal and anucleate cell for use as drug delivery system; antitumor/antiproliferative agents
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
1 ... 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 ... 3937